Related Articles by Review for PMID: 22452810

Year	Number of Results
2010	6
2011	4
2012	3
2013	7
2014	1
2016	1
2017	1
2019	1
2020	2
2021	4
2022	7
2023	6
2024	0

1

A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.

Kaur P, Nagaraja GM, Zheng H, Gizachew D, Galukande M, Krishnan S, Asea A. Kaur P, et al. BMC Cancer. 2012 Mar 27;12:120. doi: 10.1186/1471-2407-12-120. BMC Cancer. 2012. PMID: 22452810 Free PMC article.

2

Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.

Stratford AL, Reipas K, Maxwell C, Dunn SE. Stratford AL, et al. Expert Rev Mol Med. 2010 Jul 26;12:e22. doi: 10.1017/S1462399410001535. Expert Rev Mol Med. 2010. PMID: 20653987 Review.

3

Molecularly targeted therapies for metastatic triple-negative breast cancer.

Bayraktar S, Glück S. Bayraktar S, et al. Breast Cancer Res Treat. 2013 Feb;138(1):21-35. doi: 10.1007/s10549-013-2421-5. Epub 2013 Jan 29. Breast Cancer Res Treat. 2013. PMID: 23358903 Review.

4

Metastatic triple-negative breast cancer.

Rakha EA, Chan S. Rakha EA, et al. Clin Oncol (R Coll Radiol). 2011 Nov;23(9):587-600. doi: 10.1016/j.clon.2011.03.013. Epub 2011 Apr 23. Clin Oncol (R Coll Radiol). 2011. PMID: 21524569 Review.

5

Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective.

Penault-Llorca F, Viale G. Penault-Llorca F, et al. Ann Oncol. 2012 Aug;23 Suppl 6:vi19-22. doi: 10.1093/annonc/mds190. Ann Oncol. 2012. PMID: 23012297 Free article. Review.

6

'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis.

Liu N, Wang X, Sheng X. Liu N, et al. Curr Opin Obstet Gynecol. 2011 Feb;23(1):19-23. doi: 10.1097/GCO.0b013e32834252f5. Curr Opin Obstet Gynecol. 2011. PMID: 21150601 Review.

7

Treatment of triple negative breast cancer (TNBC): current options and future perspectives.

De Laurentiis M, Cianniello D, Caputo R, Stanzione B, Arpino G, Cinieri S, Lorusso V, De Placido S. De Laurentiis M, et al. Cancer Treat Rev. 2010 Nov;36 Suppl 3:S80-6. doi: 10.1016/S0305-7372(10)70025-6. Cancer Treat Rev. 2010. PMID: 21129616 Review.

8

Recent Progress in Triple Negative Breast Cancer Research.

Mouh FZ, Mzibri ME, Slaoui M, Amrani M. Mouh FZ, et al. Asian Pac J Cancer Prev. 2016;17(4):1595-608. doi: 10.7314/apjcp.2016.17.4.1595. Asian Pac J Cancer Prev. 2016. PMID: 27221827 Free article. Review.

9

Triple-negative breast cancer molecular subtyping and treatment progress.

Yin L, Duan JJ, Bian XW, Yu SC. Yin L, et al. Breast Cancer Res. 2020 Jun 9;22(1):61. doi: 10.1186/s13058-020-01296-5. Breast Cancer Res. 2020. PMID: 32517735 Free PMC article. Review.

10

Triple negative breast cancer: therapeutic and prognostic implications.

Brady-West DC, McGrowder DA. Brady-West DC, et al. Asian Pac J Cancer Prev. 2011;12(8):2139-43. Asian Pac J Cancer Prev. 2011. PMID: 22292666 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

40 results

Results by year